# A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

> **NCT01004016** · PHASE2 · COMPLETED · sponsor: **Kissei Pharmaceutical Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Spinocerebellar Degeneration

## Interventions

- **DRUG:** KPS-0373
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01004016
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2010-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01004016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01004016, "A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01004016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*